![Keith Flaherty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keith Flaherty
Fondateur chez
Strata Oncology, Inc.
Profil
Keith T.
Flaherty is the founder of X4 Pharmaceuticals, Inc., founded in 2010 and again noted in 2014, with no titles listed.
Dr. Flaherty is the founder of Strata Oncology, Inc., founded in 2015, holding the title of Director since 2015.
Dr. Flaherty was the founder of Scorpion Therapeutics, Inc., founded in 2020, with the title of Director formerly held.
Dr. Flaherty is also the founder of Apricity Health LLC..
Dr. Flaherty currently serves as Deputy Chairman at Biomarker Science Group LLC.
Dr. Flaherty is Director-Clinical Research at The Massachusetts General Hospital since 2009.
Dr. Flaherty is Editor-in-Chief at Clinical Cancer Research.
Dr. Flaherty is President-Elect at the American Association for Cancer Research, starting in 2025.
Dr. Flaherty is Professor at Harvard Medical School since 2009.
Formerly, Dr. Flaherty was Independent Director at Clovis Oncology, Inc. from 2013 to 2023.
Dr. Flaherty was Director at Loxo Oncology, Inc. from 2013 to 2019.
Dr. Flaherty was Independent Director at Checkmate Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Flaherty was Independent Director at Kinnate Biopharma, Inc. from 2019 to 2024.
Education includes undergraduate studies at Yale University and a doctorate from The Johns Hopkins University School of Medicine.
Postes actifs de Keith Flaherty
| Sociétés | Poste | Début |
|---|---|---|
The Massachusetts General Hospital
 The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Corporate Officer/Principal | 01/07/2009 |
Biomarker Science Group LLC | Directeur/Membre du Conseil | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2009 |
Strata Oncology, Inc.
 Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs | Fondateur | 01/01/2015 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | President | 28/04/2025 |
Apricity Health LLC
 Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Provides digital health related services | Fondateur | - |
Clinical Cancer Research | Corporate Officer/Principal | - |
Anciens postes connus de Keith Flaherty
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 03/04/2024 |
| CLOVIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 10/07/2023 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Keith Flaherty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
X4 Pharmaceuticals, Inc. /Old/
 X4 Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops and distributes oral small molecule CXCR4 antagonists | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clinical Cancer Research | |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Biomarker Science Group LLC | |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
Strata Oncology, Inc.
Strata Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology drugs | Health Technology |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision oncology therapies for cancer treatment | Health Technology |
Apricity Health LLC
Apricity Health LLC Miscellaneous Commercial ServicesCommercial Services Provides digital health related services | Commercial Services |
